Form 4: Opus Genetics Insider Sells Shares for Tax
Insider Transaction Report
Opus Genetics President Benjamin R Yerxa disposed of 23,795 shares of common stock at $1.95 per share to cover tax withholding obligations.
Summary
- Benjamin R Yerxa, who serves as President, Director, and Officer of Opus Genetics, Inc. (IRD), reported a transaction involving the company's common stock.
- On October 22, 2025, Yerxa disposed of 23,795 shares of common stock.
- The disposition occurred at a price of $1.95 per share.
- Following this transaction, Yerxa beneficially owns 319,005 shares of Opus Genetics common stock.
- The transaction was executed under a Rule 10b5-1(c) plan.
- The transaction code 'F' indicates that the disposition was made to the issuer to satisfy tax withholding obligations.
Sentiment
Score: 5
Explanation: The transaction is a routine disposition of shares to cover tax withholding obligations, which is generally considered neutral and not indicative of management's sentiment towards the company's future prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, tax-related disposition by an insider and does not reflect a change in fundamental outlook.
Key Dates
| Date | Description |
|---|---|
| 10/22/2025 | Transaction Date for common stock disposition |
| 10/24/2025 | Signature Date of the reporting person |
Keywords
Opus Genetics, IRD, Form 4, insider transaction, stock disposition, Benjamin R Yerxa, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.